Startup profile for Genesis AI (robotics): latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Genesis AI (robotics) funding, valuation and investors

Paris–San Carlos full-stack general-purpose robotics developer behind Eno, GENE and Genesis World.

Verified company research · funding, investors and latest developments

Keep track of Genesis AI (robotics)

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series A

$500M · November 17, 2026

Latest known valuation

$3.5B post-money (issuer-reported)

Series A · November 17, 2026

Total disclosed equity funding

$605M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series a · Paris, France and San Carlos, California, USA

Investors in latest funding

Lead: Premji Invest , Khosla Ventures , Eclipse

Other: Durable Capital Partners , Bpifrance , NVIDIA , AMD Ventures , Samsung Next

Sources: latest funding · prnewswire.com Last verified: 2026-11-18

Overview

Genesis AI is a robotics company operating from Paris and San Carlos, California, co-founded by Zhou Xian and Théophile Gervet. It develops Eno, a wheeled two-arm general-purpose robot, GENE robotics foundation models, custom dexterous hands and a data/simulation stack. It targets initial manufacturing, logistics and laboratory workflows and later hospitality, healthcare and consumer use.

The company is distinct from Genesis Molecular AI, an unrelated US drug-discovery company operating at genesis.ml.

Why Genesis AI (robotics) is interesting

On Nov 17, 2026 Genesis AI reported a $500M Series A at $3.5B post-money valuation, following a distinct $105M 2025 seed. Real robot economics and reliability remain unproven publicly: independent TechCrunch reporting describes 30–40 Eno prototypes, small undisclosed pilots and short-lived dexterous hands.

Product & use cases

Genesis AI is not a ready-to-purchase general household robot. It is developing a physical AI platform around the Eno wheeled general-purpose robot, GENE model, human-scale hand and sensor gloves that record worker actions, and Genesis World simulation. Intended buyer workflow (illustrative enterprise validation, not hands-on use): (1) a warehouse/factory/lab operator specifies one constrained repetitive task, output accuracy, worker safety and uptime; (2) Genesis and customer examine Eno's physical reach, grasp force, dexterity, sensing and the installation layout; (3) human workers wearing sensor gloves generate force/motion/video training examples, while models are trained and evaluated in simulation and on hardware; (4) run a supervised pilot and measure completed task cycles, failure rates, human interventions, hand wear and integration effort; (5) only after sustained reliability and a safety assessment negotiate scale-up/deployment. This is an illustrative procurement route, NOT an attested standardized Genesis onboarding process. Genesis unveiled Eno June 16, 2026, and announced LG CNS cooperation to evaluate industrial use. Its 2026 investor release intends production expansion and more deployments; these are goals. An independent TechCrunch reporter visited a facility and saw off-the-shelf arms perform a packing demo that struggled during a rerun; Eno itself was not demonstrated during that visit. CEO says 30–40 Enos have been built, with a few undisclosed pilots. The company's dexterous hand lasts only a few weeks in regular use, according to the interview. Public sale or leasing price, hardware bill of materials, hand replacement expense, annualized uptime, order backlog and customer ROI are not disclosed.

  • Manufacturing: fine manipulation, handling and assembly that current rigid automation struggles to generalize.
  • Logistics: packing, sorting and moving items in supervised deployments.
  • Laboratories: manipulation of tools and containers in structured environments.
  • Longer-term hospitality/healthcare/home tasks are aspirations, not evidenced commercial deployment.

Key facts

  • Nov 17 2026: $500M Series A at issuer-confirmed $3.5B post-money valuation; co-led Premji Invest, Khosla Ventures and Eclipse.
  • Historical Jul 1 2025: separate $105M seed led by Eclipse and Khosla; summing the two announcements gives $605M disclosed across these rounds, not $605M new cash in 2026.
  • Eno is wheeled, not bipedal; uses specialized dexterous hands paired with human-worn training gloves.
  • TechCrunch firsthand 17 Nov visit: demonstration of robotic arms, not Eno; imperfect repeated pack-and-label task.
  • Scale risks: hand lifetime measured in weeks according to CEO and unknown economic cost of replacement, service and reliability.

Funding history (newest first)

Series A

2026-11-17 $500M Valuation: $3.5B post-money (issuer-reported)
  • Premji Invest (lead)
  • Khosla Ventures (lead)
  • Eclipse (lead)
  • Durable Capital Partners (participant)
  • Bpifrance (participant)
  • NVIDIA (participant)
  • AMD Ventures (participant)
  • Samsung Next (participant)

Source: Read source · prnewswire.com

Seed

2025-07-01 $105M
  • Eclipse (lead)
  • Khosla Ventures (lead)
  • Bpifrance (participant)
  • HSG (participant)

Source: Read source · prnewswire.com

Competitive landscape

Edge: Vertical integration of worker-glove data acquisition, robot hand geometry, model, simulation and wheeled Eno body; not independently proven superior to all competitors in field reliability.

Compare reliability under uncontrolled objects, hand replacement cycles, data collection cost, service support, safety certification and documented signed orders rather than marketing video highlights. $500M capital raised does not establish Eno unit economics or commercial shipments.

  • Figure AI direct

    General-purpose humanoid robots with industrial ambitions; different locomotion and platform design.

  • Agility Robotics direct

    Digit bipedal industrial logistics robots, often more task-focused deployments.

  • Apptronik direct

    Apollo industrial/general-purpose humanoid with its own hardware and embodied AI approach.

  • 1X adjacent

    Consumer/home robot direction; different initial buyer and safety constraints.

  • Sanctuary AI direct

    General-purpose robotic systems emphasizing dexterous hand work and worksite automation.

Notable stories

Market / IPO context

Editorial / static context — not a live quote.

FAQs about Genesis AI (robotics)

Practical answers founders, operators, and investors typically search for.

Not established by public evidence. Genesis described pilots and plans for scaled deployments; TechCrunch reported 30–40 built units and no confirmed shipment totals.
The company has not publicly disclosed robot sale or lease pricing, maintenance terms, hand replacement costs or customer ROI.
No. This robotics company uses genesis.ai and operates from Paris/San Carlos. The unrelated drug-discovery company uses genesis.ml.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.